Reactions Weekly

, Volume 1688, Issue 1, pp 87–87 | Cite as

Dexamethasone/lenalidomide/proteasome inhibitor interaction

Ventricular tachycardia and myocardial fibrosis: case report
Case report
  • 19 Downloads

Reference

  1. Fradley MG, et al. Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British Journal of Haematology 180: 271-275, No. 2, Jan 2018. Available from: URL: http://doi.org/10.1111/bjh.14970 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations